Results 21 to 30 of about 10,335 (173)

SURGICAL TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: MODERN TRENDS AND OWN EXPERIENCE

Евразийский Кардиологический Журнал, 2016
Pulmonary endarterectomy (PEA) is the method of choice in treatment of chronic thromboembolic pulmonary hypertension (CTEPH). There are a lot of factors still restricting the widespread use of these operations.
R. S. Akchurin, K. V. Mershin, E. A. Tabakyan, R. S. Latypov, V. V. Gazizov, D. D. Tsyrenov   +5 more
doaj   +1 more source

Identification of the Novel Variants in Patients With Chronic Thromboembolic Pulmonary Hypertension

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Background Although chronic thromboembolic pulmonary hypertension (CTEPH) and acute pulmonary embolism (APE) share some clinical manifestations, a limited proportion of patients with CTEPH have a history of APE.
Nobuhiro Yaoita, Kimio Satoh, Taijyu Satoh, Toru Shimizu, Sakae Saito, Koichiro Sugimura, Shunsuke Tatebe, Saori Yamamoto, Tatsuo Aoki, Nobuhiro Kikuchi, Ryo Kurosawa, Satoshi Miyata, Masao Nagasaki, Jun Yasuda, Hiroaki Shimokawa   +14 more
doaj   +1 more source

A Health State Utility Study to Elicit Societal Values Associated with Pulmonary Hypertension

Patient Preference and Adherence, 2023
Beenish Nafees,1 Hayley M de Freitas,1 Amélie Beaudet,2 Eunju Todd,3 Wendy Gin-Sing4 1Patient-Reported Outcomes, Nafees Consulting Limited, London, UK; 2Global Market Access and Pricing, Actelion Pharmaceuticals Ltd, Allschwil, Switzerland; 3Janssen ...
Nafees B, de Freitas HM, Beaudet A, Todd E, Gin-Sing W   +4 more
doaj  

Local and systemic RAGE axis changes in pulmonary hypertension: CTEPH and iPAH. [PDF]

, 2014
OBJECTIVE:The molecular determinants of chronic thromboembolic pulmonary hypertension (CTEPH) and idiopathic pulmonary arterial hypertension (iPAH) remain poorly understood.
Roela Sadushi-Kolici, Anna Megerle, Nika Skoro-Sajer, Hendrik Jan Ankersmit, Walter Klepetko, Ana-Iris Schiefer, Peter Birner, Bernhard Moser, Michael Mildner, Tamás Szerafin, Irene Lang, Shahrokh Taghavi, Stefan Janik, Christine Bekos   +13 more
core   +1 more source

Plasma levels of high density lipoprotein cholesterol and outcomes in chronic thromboembolic pulmonary hypertension. [PDF]

PLoS ONE, 2018
BACKGROUND:High Density Lipoprotein Cholesterol (HDL-C) has various anti-inflammatory, anti-atherogenic, anti-oxidant and anti-coagulant properties that improve vascular function.
Ghaleb Khirfan, Vickram Tejwani, Xiaofeng Wang, Manshi Li, Joseph DiDonato, Raed A Dweik, Nicholas Smedira, Gustavo A Heresi   +7 more
doaj   +1 more source

Sarcopenia in Patients with Chronic Thromboembolic Pulmonary Hypertension

Journal of Cardiovascular Development and Disease
Background: Sarcopenia, or loss of skeletal muscle mass, has been associated with poor outcomes (e.g., functional decline, increased mortality, and low quality of life), but its role in CTEPH remains unclear.
Steven Hopkins, Jillian Hall, Hollie Saunders, Riyaz Bashir, Vladimir Lakhter, Anjali Vaidya, Ahmed Sadek, Paul Forfia, Estefania Oliveros   +8 more
doaj   +1 more source

Analysis of family histories suggests shared genetic risk for chronic thromboembolic pulmonary hypertension and venous thromboembolism

Pulmonary Circulation, 2022
Chronic thromboembolic pulmonary hypertension (CTEPH) and acute pulmonary embolism (PE) are related phenotypes, however, previous reports have suggested that genetic risk factors for CTEPH and PE differ.
Mark W. Dodson, Meghan M. Cirulis, C. Gregory Elliott   +2 more
doaj   +1 more source

Movahed's sign of left ventricle on myocardial perfusion scintigraphy in a case with chronic thromboembolic pulmonary hypertension

Medicine Science
Chronic thromboembolic pulmonary hypertension (CTEPH) dramatically replaces biventricular remodeling and modifies the right ventricular function. In this case, a 75-year-old female patient who was followed up with a diagnosis of chronic pulmonary ...
Fatih Bati, Guler Si̇lov, Nilufer Bicakci, Banu Kirtiloglu   +3 more
doaj   +1 more source

Incidence and predictors of chronic thromboembolic pulmonary hypertension following acute pulmonary embolism: An echocardiography guided approach

Indian Heart Journal, 2021
There is significant variability in the worldwide epidemiology of chronic thromboembolic pulmonary hypertension (CTEPH). We thereby aim to determine the incidence and predictors of CTEPH, following an episode of acute pulmonary embolism (PE), using non ...
G. Agarwal, J. Kharge, T.R. Raghu, P.S. MohanRao, C.N. Manjunath   +4 more
doaj   +1 more source

Derivation and characterisation of endothelial cells from patients with chronic thromboembolic pulmonary hypertension

Scientific Reports, 2021
Pulmonary endarterectomy (PEA) resected material offers a unique opportunity to develop an in vitro endothelial cell model of chronic thromboembolic pulmonary hypertension (CTEPH).
Olga Tura-Ceide, Valérie F. E. D. Smolders, Núria Aventin, Constanza Morén, Mariona Guitart-Mampel, Isabel Blanco, Lucilla Piccari, Jeisson Osorio, Cristina Rodríguez, Montserrat Rigol, Núria Solanes, Andrea Malandrino, Kondababu Kurakula, Marie Jose Goumans, Paul H. A. Quax, Victor I. Peinado, Manuel Castellà, Joan Albert Barberà   +17 more
doaj   +1 more source